Sep 4, 2013 9:02 AM PDT
Invivo Therapeutics Holdings Corp. (OTCBB:NVIV) has had a rough past couple of weeks, but as is the case with most panic-driven moves, this one looks like it's going to be unwound as well.
Apr 14, 2012 1:59 AM PDT
InVivo shares rallied on Friday as company announced positive developments related to its biopolymer scaffolding device.
Apr 13, 2012 9:21 AM PDT
A Market of $10 Billion Awaits.
Mar 5, 2012 10:12 AM PST
Clinical-Stage Pilot Study is Coming this Year.
Dec 21, 2011 12:02 PM PST
The Back and the Spinal Cord Need More Attention.
Nov 29, 2011 7:05 AM PST
Advanced Cell Technology (ACTC), International Stem Cell Corp (ISCOE) and Cord Blood America (CBAI) might benefit from Geron Corporation’s (GERN) exit – or they themselves could be forced to exit the stem cell market.
Nov 29, 2011 4:28 AM PST
Invivo Therapeutics Holdings (NVIV), Neuralstem (CUR) and StemCells (STEM) could benefit from Geron Corporation’s (GERN) announced exit from the stem cell research market.
Nov 22, 2011 1:39 PM PST
Advanced Cell Technology, Inc. (OTC:ACTC), Invivo Therapeutics Holdings Corp. (OTC:NVIV), and StemCells, Inc. (NASDAQ:STEM) are measured up in the spinal cord injury race.
Nov 19, 2011 6:56 AM PST
InVivo Therapeutics Holdings Corp. is engaged in the development of stem cell-based therapy for treatment of spinal cord injuries.
Nov 16, 2011 12:06 PM PST
InVivo Therapeutics Holdings Corp. is engaged in the use of polymers as a platform technology to develop treatments for spinal cord injury.